Pharmacogenetic determinants of outcome in acute lymphoblastic leukaemia. - Wikidata - awgldk - TriplyDB

Pharmacogenetic determinants of outcome in acute lymphoblastic leukaemia.

Pharmacogenetic determinants of outcome in acute lymphoblastic leukaemia.

http://www.wikidata.org/entity/Q35772582

about

Mercaptopurine/Methotrexate maintenance therapy of childhood acute lymphoblastic leukemia: clinical facts and fiction Pharmacogenomic studies of the anticancer and immunosuppressive thiopurines mercaptopurine and azathioprine Influence of folate pathway polymorphisms on high-dose methotrexate-related toxicity and survival in childhood acute lymphoblastic leukemia.Translational Rodent Models for Research on Parasitic Protozoa-A Review of Confounders and Possibilities Methylenetetrahydrofolate reductase C677T and overall survival in pediatric acute lymphoblastic leukemia: a systematic review.Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG).Predictors of acute chemotherapy-associated toxicity in patients with Ewing sarcoma Bendamustine as a model for the activity of alkylating agents.Pharmacogenomics of pediatric acute lymphoblastic leukemia.Antileukemic drug effects in childhood acute lymphoblastic leukemia.The prognostic value of glucocorticoid receptors for adult acute lymphoblastic leukemia.Association of genetic polymorphisms with hepatotoxicity in patients with childhood acute lymphoblastic leukemia or lymphoma.Novel Tetra-Primer ARMS-PCR Assays for Thiopurine Intolerance Susceptibility Mutations NUDT15 c.415C>T and TPMT c.719A>G (TPMT*3C) in East Asians.

P2860

Q27023839-00E09E28-8EE9-46B0-A5BA-BDFBFE836B44 Q33380531-64C4ABEA-1FDC-469A-9F2C-8EEA6BEB5EB7 Q33398162-00585131-177B-49D6-B0EB-BD482D661FA1 Q33770491-03032EF8-F66E-4D79-A848-2F3477B84E7D Q34336668-3D1DC3BE-01C3-4213-BFB5-D0A504B9F9DB Q35616078-E8F28B9F-0E96-4742-8EC5-BD1F3BB502E2 Q35848369-86473941-780B-4CEB-BC67-50BFCF62D5D2 Q37179377-EC2A6E2B-BA96-48E9-A88C-E3B49EA149DC Q37739432-C02BD944-4429-425B-9C67-43879646CDF5 Q38178315-1D0A0FD2-43DF-4AE5-9650-59F152EA945B Q40104215-C653AF55-480D-49AC-B380-717EB5C031CD Q42952495-57A67F7E-652C-4A5B-A9E3-052943C5AF5C Q47114058-4E5648DF-1BBF-4B2C-A5BF-ACC18C60ECBB

P2860

Pharmacogenetic determinants of outcome in acute lymphoblastic leukaemia.

http://www.wikidata.org/entity/Q35772582

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Pharmacogenetic determinants of outcome in acute lymphoblastic leukaemia.

@ast

Pharmacogenetic determinants of outcome in acute lymphoblastic leukaemia.

@en

type

label

Pharmacogenetic determinants of outcome in acute lymphoblastic leukaemia.

@ast

Pharmacogenetic determinants of outcome in acute lymphoblastic leukaemia.

@en

prefLabel

Pharmacogenetic determinants of outcome in acute lymphoblastic leukaemia.

@ast

Pharmacogenetic determinants of outcome in acute lymphoblastic leukaemia.

@en

P1433

Q35772582-28B14158-6525-460F-8E12-1DB724796202

P1476

Q35772582-1D450AE7-D370-426B-A0EB-F613EF1B9DFF

P2093

Q35772582-0346941A-41A1-4551-9545-5FEA7EEEBE2A

Q35772582-DAE718B2-A198-49B3-AEFA-5A6B4C7EACE6

P2860

Q35772582-00C5F24D-4170-4150-98A0-10522F7A1DD2

Q35772582-03897C6E-91DC-4E71-8981-2C0F4104E266

Q35772582-04578EB8-AE33-4B6D-9799-B89CCFEB9DA6

Q35772582-06E3A2A3-A5D8-4687-8457-3807C875E7CE

Q35772582-06E3EBA9-5B49-4EA9-BE49-41B2B4A5A976

Q35772582-1376330E-77AC-4CD4-B374-C55FAD077868

Q35772582-170EDF0B-296D-4A61-8F7E-12431CB2DC80

Q35772582-27131588-17B8-4DBE-B74B-ECDA623F460B

Q35772582-28BFA168-9977-496F-9F57-3EA802ECC7B8

Q35772582-32549CC5-FA3A-44CC-8710-22E6E7858A8B

P304

Q35772582-EEB92543-CCFE-4215-9572-43ADB2761C1A

P31

Q35772582-3B5DA173-8E9C-44D4-915E-829691C3913D

P356

Q35772582-84466B7E-4E5D-4D96-A63F-C86316F30AEF

P407

Q35772582-18489E1B-F8BD-416B-A92B-87829A696510

P433

Q35772582-6FB2578D-265C-4FDC-86D9-6A272980A1AA

P478

Q35772582-30C0C817-D65F-4E06-9F16-9B91993142D5

P577

Q35772582-B88EAEEC-75E5-4534-AA22-6E7063CD9DD4

P5875

Q35772582-C2D961FF-9EA0-42F2-A7F3-5177FDC1B7D5

P698

Q35772582-3059410E-E3AC-471A-B3C9-CF6A72DCC8A8

P921

Q35772582-AAB24687-9C54-4234-8143-E5F6CD7DBB2F

P356

J.1365-2141.2004.04932.X

P1433

British Journal of Haematology

P1476

Pharmacogenetic determinants of outcome in acute lymphoblastic leukaemia.

@en

P2093

Beverly Lange

http://www.w3.org/2001/XMLSchema#string

Richard Aplenc

http://www.w3.org/2001/XMLSchema#string

P2860

A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase

A polymorphism, R653Q, in the trifunctional enzyme methylenetetrahydrofolate dehydrogenase/methenyltetrahydrofolate cyclohydrolase/formyltetrahydrofolate synthetase is a maternal genetic risk factor for neural tube defects: report of the Birth Defec

Tumor necrosis factor and lymphotoxin-alpha genetic polymorphisms and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia: a case-control study of patients treated with BFM therapy

Thiopurine pharmacogenetics in leukemia: correlation of erythrocyte thiopurine methyltransferase activity and 6-thioguanine nucleotide concentrations

The human ATP-binding cassette (ABC) transporter superfamily

Genetic contribution to variable human CYP3A-mediated metabolism

Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance

Veno-occlusive disease in patients receiving thiopurines during maintenance therapy for childhood acute lymphoblastic leukaemia.

Pharmacogenomics: translating functional genomics into rational therapeutics.

Glutathione S-transferase polymorphisms and colorectal cancer: a HuGE review.

P304

421-434

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2141.2004.04932.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

125

http://www.w3.org/2001/XMLSchema#string

P577

2004-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8564188

http://www.w3.org/2001/XMLSchema#string

P698

15142113

http://www.w3.org/2001/XMLSchema#string

P921